Medivir AB Stock: price and insider trades · Sweden

Medivir AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. The last twelve months, up to 30 October 2026, brought 5 filings signed by 5 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €31k, made by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Kristian Tryggvason filed the largest purchase, €23k, on 19 June 2026, which represents 0.024% of the company's market value. Among those who bought: 2 finance chiefs and 1 board member.

Within a 30-day window, 1 purchase overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (19 June 2026) now reads 142 days. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.

For context, the typical company on the same exchange (median of 1,035 companies) published 9 filings over the same period, against 5 filings here. Our records for Medivir AB go back to 2016, with 86 purchases and 8 sales on the open market in total.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.